The treatment of myositis

How to approach resistant disease

E. M. Adams, P. H. Plotz

Research output: Contribution to journalArticle

Abstract

Idiopathic inflammatory myopathies, polymyositis, dermatomyositis, and inclusion body myositis, are increasingly recognized to cause long-term disability in certain subsets of patients. Because these diseases are infrequent, only retrospective analysis of most treatments are available. In this article, identification of subsets of patients with different prognoses and discussion of confounding factors for increasing weakness are emphasized. The advantages and disadvantages of different therapies for myositis and for extraskeletal muscle features are also discussed.

Original languageEnglish (US)
JournalRheumatic Disease Clinics of North America
Volume21
Issue number1
StatePublished - 1995
Externally publishedYes

Fingerprint

Myositis
Inclusion Body Myositis
Dermatomyositis
Muscles
Therapeutics

ASJC Scopus subject areas

  • Rheumatology

Cite this

The treatment of myositis : How to approach resistant disease. / Adams, E. M.; Plotz, P. H.

In: Rheumatic Disease Clinics of North America, Vol. 21, No. 1, 1995.

Research output: Contribution to journalArticle

@article{80c9b2d4f26548c9bddf09bbecc10077,
title = "The treatment of myositis: How to approach resistant disease",
abstract = "Idiopathic inflammatory myopathies, polymyositis, dermatomyositis, and inclusion body myositis, are increasingly recognized to cause long-term disability in certain subsets of patients. Because these diseases are infrequent, only retrospective analysis of most treatments are available. In this article, identification of subsets of patients with different prognoses and discussion of confounding factors for increasing weakness are emphasized. The advantages and disadvantages of different therapies for myositis and for extraskeletal muscle features are also discussed.",
author = "Adams, {E. M.} and Plotz, {P. H.}",
year = "1995",
language = "English (US)",
volume = "21",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The treatment of myositis

T2 - How to approach resistant disease

AU - Adams, E. M.

AU - Plotz, P. H.

PY - 1995

Y1 - 1995

N2 - Idiopathic inflammatory myopathies, polymyositis, dermatomyositis, and inclusion body myositis, are increasingly recognized to cause long-term disability in certain subsets of patients. Because these diseases are infrequent, only retrospective analysis of most treatments are available. In this article, identification of subsets of patients with different prognoses and discussion of confounding factors for increasing weakness are emphasized. The advantages and disadvantages of different therapies for myositis and for extraskeletal muscle features are also discussed.

AB - Idiopathic inflammatory myopathies, polymyositis, dermatomyositis, and inclusion body myositis, are increasingly recognized to cause long-term disability in certain subsets of patients. Because these diseases are infrequent, only retrospective analysis of most treatments are available. In this article, identification of subsets of patients with different prognoses and discussion of confounding factors for increasing weakness are emphasized. The advantages and disadvantages of different therapies for myositis and for extraskeletal muscle features are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0028855787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028855787&partnerID=8YFLogxK

M3 - Article

VL - 21

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 1

ER -